Carcinogenesis Advance Access published online on February 20, 2006
Carcinogenesis, doi:10.1093/carcin/bgi356
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 UMR7147 Institut Curie-CNRS-UPMC, CEA LRC38, Institut Curie, Paris, France
* To whom correspondence should be addressed. The mutagenic properties of ionizing-radiation are well known, but the presence of specific mutations in human radiation-induced tumours is not established. We have studied a series of 36 secondary sarcomas arising in the irradiation field of a primary tumour following radiotherapy. The allelic status and the presence of mutations of the TP53 gene were investigated. The mutation pattern was compared with data from sporadic sarcomas recorded in the IARC TP53 somatic mutations database. A high proportion (58%) of the radiation-induced sarcomas exhibited a somatic inactivating mutation for one allele of TP53, systematically associated with a loss of the other allele. The high frequency (52%) of short deletions observed in the mutation pattern of radiation-induced sarcomas may be related to the induction of DNA breaks by ionizing radiation. The lack of hyper-reactivity of CpG dinucleotides and the presence of recurrent sites of mutation at codons 135 and 237 seem also to be specific for radiation-tumorigenesis.
Received December 12, 2005
Revised January 20, 2006
Accepted January 23, 2006
CARCINOGENESIS
Specific TP53 mutation pattern in radiation-induced sarcomas
Nathalie Gonin-Laurent 1,
Anne Gibaud 1,
Mathilde Huygue 1,
Sandrine H. Lefèvre 1,
Morgane Le Bras 2,
Laurent Chauveinc 3,
Xavier Sastre-Garau 4,
François Doz 5,
Livia Lumbroso 6,
Sylvie Chevillard 7,
and
Bernard Malfoy 1 *
2 Génotoxicologie des Tumeurs, Institut Curie, Paris, France
3 Service de Radiothérapie, Institut Curie, Paris, France
4 Service de Pathologie, Institut Curie, Paris, France
5 Departement de Pédiatrie, Institut Curie, Paris, France
6 Service d'Ophtalmologie, Institut Curie, Paris, France
7 CEA, DSV DRR, Fontenay-aux-Roses, France
Bernard Malfoy, E-mail: bernard.malfoy{at}curie.fr
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Manie, A. Vincent-Salomon, J. Lehmann-Che, G. Pierron, E. Turpin, M. Warcoin, N. Gruel, I. Lebigot, X. Sastre-Garau, R. Lidereau, et al. High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors Cancer Res., January 15, 2009; 69(2): 663 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Walkley, R. Qudsi, V. G. Sankaran, J. A. Perry, M. Gostissa, S. I. Roth, S. J. Rodda, E. Snay, P. Dunning, F. H. Fahey, et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease Genes & Dev., June 15, 2008; 22(12): 1662 - 1676. [Abstract] [Full Text] [PDF] |
||||

